AC
ALT icon

AXQ Capital’s Altimmune ALT Stock Holding History

AXQ Capital’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Buy
56,810
+9,058
+19% +$27.1K 0.02% 744
2026
Q1 		$147K Buy
47,752
+22,051
+86% +$93.6K 0.02% 814
2025
Q4 		$92.8K Buy
25,701
+5,266
+26% +$23K 0.02% 664
2025
Q3 		$77K Sell
20,435
-20,847
-50% -$80.5K 0.03% 529
2025
Q2 		$160K Buy
+41,282
New +$223K 0.05% 482
2025
Q1 		– Sell
-12,388
Closed -$89.3K – 487
2024
Q4 		$89.3K Sell
12,388
-11,107
-47% -$84.9K 0.04% 382
2024
Q3 		$144K Buy
+23,495
New +$159K 0.04% 388

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AXQ Capital's ALT Position: Q2 2026 in Review

AXQ Capital increased its Altimmune (ALT) stake by 19% in Q2 2026, buying an estimated $27.1K and bringing the position to 56,810 shares worth $173K. The position accounts for 0.02% of the portfolio, ranked #744.

AXQ Capital first reported a position in ALT in Q3 2024 and has held it in 7 quarters since. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • AXQ Capital held 56,810 shares of Altimmune worth $173K as of Q2 2026.
  • AXQ Capital bought 9,058 Altimmune shares in Q2 2026, an estimated $27.1K.
  • Altimmune made up 0.02% of AXQ Capital's portfolio in Q2 2026, its #744 holding.
  • AXQ Capital first reported a position in Altimmune in Q3 2024 and has held it in 7 quarters since.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.